References
Appel, N.M., Contrera, J.F. and De Souza, E.B. (1989) Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies. J. Pharmacol. Exp. Ther.249, 928–943.
Ballard, P.A., Tetrud, J.W. and Langston, J.W. (1985) Permanent human parkinsonism due to l-methyl-4-phe-nyl-l, 2, 3, 6-tetrahydropyridine (MPTP): seven cases. Neurology,35, 949–956.
Barnes, D.M. (1989) Neurotoxicity creates regulatory dilemma. Science243, 29–30.
Blomqvist, O., Soderpalm, B. and Engel, J. (1992) Etha-nol-induced locomotor activity: Involvement of central nicotinic acetylcholine receptors? Brain Res. Bull.29, 173–178.
Blomqvist, O., Engel, J.A., Nissbrandt, N. and Soderpalm, B. (1993) The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine. Europ. J. Pharmacol.,249, 207–213.
Cavanagh, J.B. (1995) Principles of Neurotoxicity. New York: Marcel Dekker.
Eriksson, P., Ankarberg, E., Viberg, H. and Fredriksson, A. (2000) The developing cholinergic system as target for environmental toxicants, nicotine and polychlorinated biphenyls (PCBs): Implications for neurotoxicological processes. Neurotoxicity Res. 2, abc-xyz. (In press, this issue).
Fredriksson, A., Eriksson, P., Ankarberg, E., Palomo, T. and Archer, T. (2000) Neonatal nicotine administration influences ethanol-induced behaviours. Alcohol in press.
Friedlich, A.L. and Beal, F. (2000) Prospects for redox-based therapy in neurodegenerative diseases. Neurotoxicity Res. 2, abc-xyz. (In press, this issue).
Gamma, A., Frei, E., Lehmann, D., Pascual-Marqui, R.D., Hell, D. and Vollenweider, F.X. (2000) Mood state and brain electric activity in ecstasy users. Neuroreport11, 157–162.
Gingras, J.L., Weese-Mayer, D.E., Hume, Jr. R.E. and O’Donnell, K.J. (1992) Cocaine and development: mechanisms of fetal toxicity and neonatal consequences of prenatal cocaine exposure. Early Human Dev.31, 1–24.
Gorriti, M.A., Rodriguez de Fonseca, F.A., Navarro, M. and Palomo, T. (1999) Chronic treatment with (-)-delta-9-tet-rahydrocannabinol results in sensitization to the psicomotor effects of amphetamine. Eur. ]. Pharmacol.365, 133–142.
Green, A.R., Cross, A.J. and Goodwin, G.M. (1995) Review of the pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA or Ecstasy). Psychopharmacology119, 247–260.
Harvey, J.A., Romano, A.G., Gabriel, M., Simansky, K.J., Du, W., Aloyo, V.J. and Friedman, E. (2000) Effects of prenatal exposure to cocaine on the developing brain: Anatomical, chemical, physiological and behavioral consequences. Neurotoxicity Res. 2, abc-xyz. (In press, this issue).
Heimer, L. and Alheid, G. (1991) Piecing together the puzzle of basal forebrain anatomy. In: Napier, T.C., Kalivas, P. and Hanin, I. (Eds.), The Basal Porebrain: Anatomy to Function (New York, Plenum Press), pp. 1–42.
Kleven, M.S. and Seiden, L.S. (1989) D-, L- and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain. Brain Res.505, 351–353.
Koehl, M., Lemaire, V., Vallee, M., Abrous, N., Piazza, P.V., Mayo, W., Maccari, S. and LeMoal, M. (2000) Long term neurodevelopmental and behavioral effects of perinatal life events in rats. Neurotoxicity Res. 2, abc-xyz. (In press, this issue).
Langston, J.W. and Ballard, P.A. (1984) Parkinsonism induced by l-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine (MPTP): implications for the treatment and the pathogenesis of Parkinson’s disease. Can. J. Neurol. Sci.11, 160–165.
LeMoal, M. and Simon, H. (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev.71, 155–234.
Lew, R., Sabol, K.E., Chou, C, Vosmer, G.L., Richards, J. and Seiden, L.S. (1996) Methylenedioxymethamphetamine (MDMA)-induced serotonin deficits are followed by partial recovery over a 52 week period. Part II: Radioligand binding and autoradiographic studies. J. Pharmacol. Exp. Ther.276, 855–865.
Liester, M.B., Grob, C.S., Bravo, G.L and Walsh, R.N. (1992) Phenomenology and sequelae of 3, 4-methylenedioxymethamphatamine use. J. Nerv. Merit. Dis.180, 345–352.
Luthman, J., Fredriksson, A., Lewander, T., Jonsson, G. and Archer, T. (1989) Effects of d-amphetamine and methyl-phenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment. Psychopharmacology (Berl.)99, 550–557.
McCann, U.D., Mertl, M.M., Eligulashvili, V. and Ricaurte, G.A. (1999) Cognitive performance in (±) 3, 4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: A controlled study. Psychopharmacology143, 417–425.
Navarro, M., Martm-Calderon, J.L., del Arco, L, Villanua, M.A., Sanchez, L., Mufioz, R.M., Orengo, F., Capdevilla, E., Chowen, J. and Rodriguez de Fonseca, F. (1999) Effects of subchronic treatment with dopaminergic agonists and antagonists on the acute sensitivity to cannabi-noid exposure: behavioural, neurochemical and hormonal studies. In Interactive Monoaminergic Disorders. Eds. Palomo, T., Beninger, RJ. and Archer, T. pp. 291–310. Madrid: Editorial Sintesis.
Piazza, P.V. and LeMoal, M. (1997) Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res. Rev.25, 359–372.
Piazza, P.V. and LeMoal, M. (1998) The role of stress in drug self-administration. Trends Pharmacol. Sci.19, 67–74.
Piazza, P.V., Rouge-Pont, F., Deroche, V., Maccari, S., LeMoal, M. and Simon, H. (1996) Glucocorticoids have state-dependent stimulant effects on mesencephalic dopaminergic transmission. Proc. Nat. Acad. Sci. U.S.A.93, 8716–8720.
Planeta, C.S., Berliner, J., Russ, A. and Kosofsky, B.E. (2000) The effect of prenatal cocaine exposure on the stress response of adult mice. Neurotoxicity Res. 2, abc-xyz. (In press, this issue).
Ricaurte, G.A. and McCann, U.D. (2000) Experimental studies on 3, 4-methylenedioxymethamphetamine (MDMA, “ecstasy”) and its potential to damage brain serotonin neurons. Neurotoxicity Res. 2, abc-xyz. (In press, this issue).
Rodriguez de Fonseca, F., Gorriti, M.A., Bilbao, A., Escuredo, L., Garcia-Segura, L.M., Piomelli, D. and Navarro, M. Role of endogenous cannabinoid system as a modulator of dopamine transmission: Implications for Parkinson’s disease and schizophrenia. Neurotoxicity Res. 2, abc-xyz. (In press, this issue).
Schmidt, C.J. and Taylor, V.L. (1987) Depression of rat brain tryptophan hydroxylase following acute administration of methylenedioxymethamphetamine. Biochem. Pharmacol.36, 4095–4102.
Seiden, L.S., Lew, R. and Malberg, J.E. (2000) Neurotoxicity of methamphetamine and methylenedioxymethamphetamine. Neurotoxicity Res. 2, abc-xyz. (In press, this issue).
Seiden, L.S., Sabol, K.E. and Dyer, R.S. (1995) Neurotoxicity of methamphetamine-related drugs and cocaine. In Handbook of Neurotoxicity. Ed. Chang, L.W. pp. 825–843. New York: Marcel Dekker.
Van Praag, H. (1999) Could some depressions be conditioned by derailment of serotonin /cortisol interaction? In Interactive Monoaminergic Disorders. Eds. Palomo, T., Beninger, R.J. and Archer, T. pp. 91–105. Madrid: Editorial Sintesis.
Weiss, F. and Koob, G.F. (2000) Drug addiction: Functional neurotoxicity of the brain reward systems. Neurotoxicity Res. 2, abc-xyz. (In press, this issue).
Zaczek, R., Battaglia, G., Culp, S., Appel, N.M., Contrera, J.F. and DeSouza, E.B. (1990) Effects of repeated administration of fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetics, dose response, regional specificity and time course data. J. Pharmacol. Exp. Ther.253, 104–112.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Archer, T., Palomo, T. & Kostrzewa, R.M. Neurotoxicity and substance abuse: Further fuel for regulatory dilemma. neurotox res 3, 1–6 (2001). https://doi.org/10.1007/BF03033226
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033226